DGCR6L Antikörper (C-Term)
Kurzübersicht für DGCR6L Antikörper (C-Term) (ABIN926625)
Target
Alle DGCR6L Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Aufreinigung
- Purified
-
Immunogen
- DGCR6 L antibody was raised in rabbit using the C terminal of DGCR6 as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
DGCR6L Blocking Peptide, (ABIN5613187), is also available for use as a blocking control in assays to test for specificity of this DGCR6L antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- DGCR6L (DiGeorge Syndrome Critical Region Gene 6-Like (DGCR6L))
-
Andere Bezeichnung
- DGCR6L
-
Hintergrund
- This gene, the result of a duplication at this locus, is one of two functional genes encoding nearly identical proteins that have similar expression patterns. The product of this gene is a protein that shares homology with the Drosophila gonadal protein, expressed in gonadal tissues and germ cells, and with the human laminin gamma-1 chain that functions in cell attachment and migration. This gene is located in a region of chromosome 22 implicated in the DiGeorge syndrome, one facet of a broader collection of anomalies referred to as the CATCH 22 syndrome. Synonyms: Polyclonal DGCR6L antibody, Anti-DGCR6L antibody, DiGeorge syndrome critical region gene 6-like antibody, FLJ10666 antibody.
Target
-